Abiopharma

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

National Healthcare Properties Provides Business Updates

Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $0.72 per Common Share for 2Q26

SOLAI Announces Agreement to Acquire 51% Stake in NEURALAND

Servier to Acquire Edgewise Therapeutics Muscular Dystrophy Business USA - English USA - English USA - Français

INNOVATE Announces Successful Closing of Broadcasting Refinancing and Agrees to Partial Sale of Broadcasting

JET.AI ANNOUNCES LEADING INDEPENDENT PROXY ADVISORY FIRM GLASS LEWIS RECOMMENDS STOCKHOLDERS VOTE “FOR” THE PROPOSED MERGER

Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting

Everus Announces Promotions of Behring, Hendricks

Servier projette dacquérir lactivité dystrophie musculaire dEdgewise Therapeutics USA - Français USA - English USA - English